apoio social e hipertension arterial esencial - Universidade de Vigo
apoio social e hipertension arterial esencial - Universidade de Vigo
apoio social e hipertension arterial esencial - Universidade de Vigo
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
ANEXO 9: GRAO DE CONTROL DA TENSION ARTERIAL O FINAL DO<br />
ESTUDIO : VARIABLES CLINICAS E DE ADHERENCIA<br />
VARIABLE<br />
SISTOLICA<br />
Bo control Mal<br />
control<br />
DIFER<br />
ENCIA<br />
P<br />
IC(95%)<br />
DIASTOLICA<br />
Bo control Mal control<br />
IDADE en 59.20 64.99 5.70 P=0.002 64.65 60.89<br />
anos DE 12.24 DE 10.1<br />
9.34;2.22<br />
DE 10.71 DE 11.04<br />
SEXO Home (12)20.3% (47)79.7% 10.2 P=0.15 (35)59.3% (24)40.7%<br />
Muller (36)30.5% (82)69.5%<br />
24.6;-4.2<br />
(84)71.2% (34)28.8%<br />
TABACO Si (2)16.6% (10)83.4% 11.3 P=0.39 (7)53.8% (5)41.7%<br />
Non (43)27.9% (111)72.1<br />
-38;15.4<br />
(105)68.1% (49)31.9%<br />
ALCOHOL #39g/día (39)34.2% (105)65.8 8.1 P=0.92 (98)68.1% (46)31.9%<br />
∃40g/día (6)26.1% (17)73.9%<br />
-13.9;30.1<br />
(15)65.2% (8)34.8%<br />
DIABETE Si (4)15.3% (22)84.7% 13.8 P=0.14 (15)57.6% (11)43.4%<br />
Non (44)29.1% (107)70.9<br />
31.6;-4.0<br />
(104)68.8% (47)31.2%<br />
OBESIDADE Si (20)27.7% (52)72.3% 1.1 P=0.87 (40)55.5% (32)44.5%<br />
Non (28)26.6% (77)73.4%<br />
-13.4;15.6<br />
(79)75.2% (26)24.8%<br />
DISLIPEMIA Si (12)27.9% (31)72.1% 1.1 P=0.89 (28)65.1% (15)34.9%<br />
Non (36)26.8% (98)73.2%<br />
-15.7;17.9<br />
(91)63.1% (43)36.9%<br />
GRAO I-II (40)30.1% (93)69.9% 11.5 P=0.12 (87)65.4% (46)34.6%<br />
HTA III-IV (8)18.6% (36)81.4%<br />
-3.9;26.9<br />
(32)72.7% (12)27.3%<br />
SEVERIDADE Si (13)35.1% (24)64.9% 10-1 P=0.21 (24)64.8% (13)35.2%<br />
HTA<br />
non (35)25% (105)75<br />
(95)67.8% (45)32.2%<br />
(repercusión visceral)<br />
-8.5;28.7<br />
USO DE Si (41)28.8% (101)71.2 8.8 P=0.29 (100)70.4% (42)29.6%<br />
FARMACOS Non (7)20% (28)80%<br />
-8.1;25.7<br />
(19)54.2% (16)45.8%<br />
ADHERENCIA Boa (10)16.1% (52)83.9% 16.3 P=0.02 (40)64.5% (22)35.5%<br />
A DIETA<br />
OBSERVANCIA<br />
OS FARMACOS<br />
mala (35)32.4% (73)67.6%<br />
30.2;2.3<br />
(74)68.5% (34)31.5%<br />
MEDIDA POR:<br />
Autoinformado Boa (36)27.2% (96)72.8% 8.5 P=0.50 (90)90% (10)10%<br />
Polo paciente mala (5)35.7% (9)64.3%<br />
-38.6;21.6<br />
(42)91.3% (4)8.7%<br />
Contaxe <strong>de</strong> Boa (38)31.1% (85)68.2% 24.2 P=0.07 (90)73.1% (33)26.9%<br />
Comprimidos mala (1)7.6% (12)92.4%<br />
-3.3;45 (7)53.8% (6)46.2%<br />
Coñecemento Boa (23)41.1% (33)58.9% 20.3 P=0.004 (41)73.2% (15)26.8%<br />
Da enfermida<strong>de</strong> mala (25)20.8% (95)79.2%<br />
4.1;36.4<br />
(78)65% (42)35%<br />
143<br />
DIFE<br />
REN<br />
P<br />
CIA<br />
IC(95%)<br />
3.76 P=0.03<br />
0.33;7.18<br />
11.9 P=0.11<br />
28.1;-4.3<br />
9.8 P=0.48<br />
-43.1;23.5<br />
2.9 P=0.78<br />
-20.5;26.3<br />
12.4 P=0.26<br />
-10.3;35.1<br />
19.7 P=0.006<br />
4.3;35<br />
2 P=0.73<br />
-15.9;19.9<br />
7.3 P=0.37<br />
-24.2;9.6<br />
3 P=0.73<br />
-21.9;15.9<br />
16.2 P=0.06<br />
-3.7;36.1<br />
4 P=0.59<br />
-20.0;12.0<br />
1.3 P=0.80<br />
-12.9;10.3<br />
19.3 P=0.14<br />
-13.2;5.8<br />
8.2 P=0.27<br />
-7.5;23.9
Change language